Genetic variants of NHEJ DNA ligase IV can affect the risk of developing multiple myeloma, a tumour characterised by aberrant class switch recombination

Journal of Medical Genetics

Volumn 39, Issue 12, 2002, Pages 900-905

  Roddam, P L ^a   Rollinson, S ^a   O'Driscoll, M ^b   Jeggo, P A ^b   Jack, A ^a   Morgan, Gareth J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA LIGASE 4; DOUBLE STRANDED DNA; IMMUNOGLOBULIN; LYMPHOCYTE ANTIGEN RECEPTOR; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; UNCLASSIFIED DRUG;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CONTROLLED STUDY; DNA REPAIR; DNA STRAND BREAKAGE; ENZYME STRUCTURE; GENE LINKAGE DISEQUILIBRIUM; GENE REARRANGEMENT; GENE SWITCHING; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RECOMBINATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; INHERITANCE; LEUKEMIA; LIG4 GENE; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; PRIORITY JOURNAL; RECEPTOR GENE; STATISTICAL SIGNIFICANCE; TUMOR GROWTH;

EID: 0036909535     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.39.12.900     Document Type: Article

References (34)

1. Vanasse G J, Concannon P, Willerford DM. Regulated genomic instability and neoplasia in the lymphoid lineage. Blood 1999;94:3997-4010.
2. Kanaar R, Hoeijmakers JHI, van Gent DC. Molecular mechanisms of DNA double-strand break repair. Trends Cell Biol 1998;8:483-9.
3. van Gent DC, Hoeijmakers JHI, Kanaar R. Chromosomal stability and the DNA double-stranded break connection. Nat Genet 2001;2:196-206.
4. Frank KM, Sekiguchi JAM, Seidl KJ, Swat W, Rathburn GA, Cheng HL, Davidson L, Kangaloo L, Alt FW. Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV. Nature 1998;396:173-7.
5. Taccioli GE, Amatucci AG, Beamish HJ, Gell D, Xiang XH, Torres Arzayus MI, Priestley A, Jackson SP, Rothstein AM, Jeggo PA, Herrera VLM. Targeted disruption of the catalytic subunit of the DNA-PK gene in mice confers severe combined immunodeficiency and radiosensitivity. Immunity 1998;9:355-66.
6. Manis JP, Gu Y, Lansford R, Sonoda E, Ferrini R, Davidson L, Rajewsky K, Alt Fw. Ku70 is required for late B cell development and immunoglobulin heavy chain class switching. J Exp Med 1998;187:2081-9.
7. Grawunder U, Zimmer D, Fugmann S, Schwarz K, Lieber MR. DNA ligase IV is essential for V(D)J recombination and DNA double-strand break repair in human precursor lymphocytes. Mol Cell 1998;2:477-84.
8. C3) or recombination-activating gene (RAG-1) activity. J Exp Med 2000;192:1509-14.
9. Singleton BK, Priestley A, Steingrimsdottir H, Gell D, Blunt T, Jackson SP, Lehmann AR, Jeggo PA. Molecular and biochemical characterisation of xrs mutants defective in Ku80. Mol Cell Biol 1997;17:1264-73.
10. Grawunder U, Zimmer D, Kulesza P, Lieber MR. Requirement for an interaction of XRCC4 with DNA ligase IV for wild-type V(D)J recombination and DNA double-strand break repair in vivo. J Biol Chem 1998;273:24708-14.
11. Gao, Y, Ferguson DO, Xie W, Manis JP, Sekiguchi JA, Frank KM, Chaudhuri J, Horner J, DePinho RA, Alt FW. Interplay of p53 and DNA-repair protein XRCC4 in tumourgenesis, genomic stability and development. Nature 2000;404:897-900.
12. Ferguson DO, Sekiguchi JAM, Chang S, Frank KM, Gao Y, DePinho RA, Alt FW. The nonhomologous end-joining pathway of DNA repair is recuired for genomic stability and the suppression of translocations. Proc Natl Acad Sci USA 2000;97:6630-3.
13. Sekiguchi J, Ferguson DO, Chen HT, Yang EM, Earle J, Frank K, Whitlow S, Gu Y, Xu Y, Nussenzweig A, Alt FW. Genetic interactions between ATM and the nonhomologous end-joining factors in genome stability and development. Proc Natl Acad Sci USA 2001;98:3243-8.
14. Roth DB, Gellert M. New guardians of the genome. Nature 2000;404:823-5.
15. Difilippantonio MJ, Zhu J, Chen HT, Meffre E, Nussenzweig MC, Max EE, Reid T, Nussenzweig A. DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature 2000;404:510-14.
16. Gennery AR, Cant AJ, Jeggo PA. Immunodeficiency associated with DNA repair defects. Clin Exp Immunol 2000;121:1-7.
17. Riballo E, Critchlow SE, Teo SH, Doherty AJ, Priestley A, Broughton B, Kysela B, Beamish H, Plowman N, Arlett CF, Lehmann AR, Jackson SP, Jeggo PA. Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient. Curr Biol 1999;9:699-702.
18. O'Driscoll M, Cerosaletti KM, Girard P-M, Dai Y, Stumm M, Kysela B, Hirsch B, Gennery A, Palmer SE, Seidel J, Gatti RA, Varon R, Oettinger MA, Neitzel H, Jeggo PA, Concannon P. DNA ligase IV mutations identified in patients exhibiting development delay and immunodeficiency. Mol Cell 2001;8:1175-85.
19. Grawunder U, Zimmer D, Lieber MR. DNA ligase IV binds to XRCC4 via a motif located between rather than within its BRCT domains. Curr Biol 1998;8:873-6.
20. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Ann Oncol 1999;10:1419-143.
21. Kuppers R, Dalla-Favera R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 2001;20:5580-94.
22. Roddam PL, Rollinson S, Kane E, Roman E, Moorman A, Morgan GJ. Risk of adult acute leukaemia associated with polymorphism at the cytochrome P450 2D6 and 2C19 loci. Pharmacogenetics 2000;10:605-15.
23. Vaandrager JW, Schuuring E, Philiippo K, Kluin PM. V(D)J recombinase-mediated transposition of the BCL2 gene to the IGH locus in follicular lymphoma. Blood 2000;96:1947-52.
24. Grawunder U, Harfst E. How to make ends meet in V(D)J recombination. Curr Opin Immunol 2001;13:186-94.
25. Papavasiliou F, Case las R, Suh H, Qin XF, Besmer E, Pelanda R, Nemazee D, Rajewsky K, Nussenweig MC. V(D)J recombination in mature B cells: A mechanism for altering antibody responses. Science 1997;278:298-301.
26. Storb U, Shen HM, Michael N, Kim N. Somatic hypermutation of immunoglobulin and non-immunoglobulin genes. Philos Trans R Soc B 2001;356:13-9.
27. Fenton JAL, Vaandrager JW, Aarts WM, Bende RJ, Heering K, van Dijk M, Morgan GJ, van Noesel CJM, Schurring E, Kluin PM. Follicular lymphoma with a novel t(14;18) breakpoint involving the immunoglobulin heavy chain switch mu region indicates an origin from germinal centre B cells. Blood 2002;99:716-18.
28. Fenton JAL, Pratt G, Rawstron AC, Morgan GJ. Isotype class switching and the pathogenesis of multiple myeloma. Hematol Oncol 2002;19:1-12.
29. Ehrenstein MR, Rodo C, Jorres AM, Milstein C, Neuberger MS. Switch junction sequences in PMS2-deficient mice reveal a microhomology-mediated mechanism of Ig class switch recombination. Proc Natl Acad Sci USA 2001;98:14553-8.
30. Kinoshita K, Honjo T. Linking class-switch recombination with somatic hypermutation. Nat Rev Mol Cell Biol 2001;2:493-503.
31. Chen L, Trujillo K, Sung P, Tomkinson AE. Interactions of the DNA ligase IV-XRCC4 complex with DNA ends and the DNA-dependent protein kinase. J Biol Chem 2000;275:26196-205.
32. Bryans M, Valenzano MC, Stamato TD. Absence of DNA ligase IV protein in XR-1 cells: Evidence for stabilization by XRCC4. Mutat Res 1999;433:53-8.
33. Modesti M, Hesse JE, Gellert M. DNA binding of Xrrc4 protein is associated with V(D)J recombination but not with stimulation of DNA ligase IV activity. EMBO J 1999;18:2008-18.
34. Junop MS, Modesti M, Guarne A, Ghirlando R, Gellert M, Yang W. Crystal structure of the Xrcc4 DNA repair protein and implications for end joining. EMBO J 2000;19:5962-70.